Genetic risk for heat stroke study
Part of Hormones & metabolism, Injuries & trauma clinical trials.
This study looks for a possible genetic link to heat stroke. Researchers will compare heat responses in people who carry the cystic fibrosis gene against those who do not.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must already know your genetic status as either a cystic fibrosis (CF) carrier or a healthy control.
- You must be comfortable reading and speaking English.
- You cannot have type 1 or type 2 diabetes.
- You cannot have a history of heart problems such as heart attack, stroke, heart failure, or hardening of the arteries.
- You cannot be pregnant or taking heart medications like beta blockers or water pills.
- You cannot be in prison and must be able to sign your own consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether carrying one CF gene (being a “CF carrier”) changes the risk of getting respiratory infections. It may help researchers understand how genetics can affect lung health, even for people who do not have cystic fibrosis.
This study looks at whether people who carry one cystic fibrosis (CF) gene change have differences in the kidneys and pancreas. You may be able to help researchers learn early effects and better health monitoring for CF carriers.
This study looks at how well the body controls temperature during exercise after a past heat-stroke episode, in a military setting. It may help improve safety and recovery plans for people who have had exercise-related heat stroke.
This trial studies how to better recognize worsening heat stroke early and predict outcomes. If you’ve had heat stroke, it may help improve monitoring and treatment planning for future patients.
This study looks at genetic (inherited DNA) factors that may influence who develops diabetes related to cystic fibrosis. Your results could help doctors better predict risk and improve care for cystic fibrosis and related diabetes.
This trial tests a new device that measures how your sweat glands react to a common asthma medication. It aims to better classify people with cystic fibrosis or related diseases, and also includes healthy volunteers and carriers.
Hear when a new Carrier State trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.